| Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos A Cabo-Meseguer, G Cerdá-Olmedo, JL Trillo-Mata Medicina clínica 149 (10), 441-448, 2017 | 383 | 2017 |
| Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups D Vivas-Consuelo, R Usó-Talamantes, JL Trillo-Mata, ... Health Policy 116 (2-3), 188-195, 2014 | 44 | 2014 |
| Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool D Vivas-Consuelo, R Usó-Talamantes, N Guadalajara-Olmeda, ... BMC health services research 14, 1-11, 2014 | 27 | 2014 |
| Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain R Cantón, R Huarte, L Morata, JL Trillo-Mata, R Muñoz, J González, ... Enfermedades Infecciosas y Microbiología Clínica 39 (4), 179-183, 2021 | 22 | 2021 |
| Epidemiología y caracterización sociodemográfica de la fibromialgia en la Comunidad Valenciana A Cabo-Meseguer, G Cerdá-Olmedo, JL Trillo-Mata Revista española de salud pública 93, e201912099, 2020 | 22 | 2020 |
| Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis MT Álvarez-Román, I Cuervo-Arango, R Pérez-Santamarina, JL Poveda, ... Global & Regional Health Technology Assessment 2019, 2284240319880534, 2019 | 15 | 2019 |
| Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study J Sanfélix-Genovés, S Peiró, G Sanfélix-Gimeno, I Hurtado, ... BMC Health Services Research 10, 1-7, 2010 | 12 | 2010 |
| The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis A Gil-Nagel, M Falip, R Sánchez-Carpintero, MR Abad-Sazatornil, ... Epilepsy & Behavior 132, 108711, 2022 | 11 | 2022 |
| Sistema de Prescripción y dispensación electrónica en la Agencia Valenciana de Salud E De la Poza, I Barrachina Martínez, JL Trillo Mata, R Usó Talamantes El profesional de la información 20 (3), 332-339, 2011 | 10 | 2011 |
| Cost of Type 2 diabetes patients with chronic kidney disease based on real-world data: an observational population-based study in Spain R Usó-Talamantes, S González-de-Julián, J Díaz-Carnicero, ... International Journal of Environmental Research and Public Health 18 (18), 9853, 2021 | 9 | 2021 |
| Methods to control the pharmaceutical cost impact of chronic conditions in the elderly D Vivas-Consuelo, R Usó-Talamantes, JL Trillo-Mata, P Mendez-Valera Expert Review of Pharmacoeconomics & Outcomes Research 15 (3), 425-437, 2015 | 5 | 2015 |
| Desarrollo del indicador población estandarizada equivalente para el control del gasto farmacéutico ambulatorio M Caballer Tarazona, L Buigues Pastor, I Saurí Ferrer, R Usó Talamantes, ... Revista Española de Salud Pública 86 (4), 371-380, 2012 | 5 | 2012 |
| Sistemas de información sanitaria de la Conselleria de Sanitat de la Comunidad Valenciana. GAIA: Gestor de prestación farmacéutica JL Trillo Mata, M Pascual de la Torre, A Perales Marín, P Villalba-Garnica, ... Farm At Primaria. 1, 14-24, 2003 | 5 | 2003 |
| Influencia de las características del médico de AP y del cupo en el precio medio de la recetay el porcentaje de genéricos prescritos en un área de salud de la Comunidad Valenciana V Pedrera Carbonell, H Schwarz Chavarri, M Pascual de la Torre, ... Cuad. gest. prof. aten. prim.(Ed. impr.), 157-165, 2003 | 4 | 2003 |
| Analysis of potentially inappropriate prescriptions according to the START criteria in nursing homes D Planelles, S Ferrer, JL Trillo-Mata, J Navarro-Pérez Revista Espanola de Geriatria y Gerontologia 56 (4), 195-202, 2021 | 3 | 2021 |
| Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos AC Meseguer, G Cerdá-Olmedo, JLT Mata Medicina clínica 149 (10), 441-448, 2017 | 3 | 2017 |
| PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in Valencia RU Talamantes, MC Tarazona, LB Pastor, JLT Mata, NG Olmeda, ... Value in Health 14 (7), A341, 2011 | 3 | 2011 |
| EE145 cost-effectiveness analysis of the novel powered circular stapler in colorectal anastomosis surgery SG de Julián, CR Muñoz, IB Martínez, D Vivas-Consuelo, VP Martí, ... Value in Health 25 (12), S81, 2022 | 2 | 2022 |
| Epidemiology and sociodemographic characterization of the fibromyalgia in Comunidad Valenciana A Cabo-Meseguer, G Cerdá-Olmedo, JL Trillo-Mata Revista Española de Salud Pública 93, e201912099-e201912099, 2019 | 2 | 2019 |
| Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community M Romero, RU Talamantes, DV Consuelo, E De la Poza Plaza, ... Value in Health 16 (7), A691, 2013 | 2 | 2013 |
